Antrocin sensitizes prostate cancer cells to radiotherapy through inhibiting PI3K/AKT and MAPK signaling pathways

Yu An Chen, David T.W. Tzeng, Yi Ping Huang, Chun Jung Lin, U. Ging Lo, Chia Lin Wu, Ho Lin, Jer Tsong Hsieh, Chih Hsin Tang*, Chih Ho Lai

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Antrocin sensitizes prostate cancer cells to radiotherapy through inhibiting PI3K/AKT and MAPK signaling pathways'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science